Hans E. Bishop's most recent trade in Sana Biotechnology Inc was a trade of 80,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2025 | 16,339 | 5,821,113 | - | 0 | Common Stock | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 14,285 | 5,804,774 | - | 0 | Common Stock | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2024 | 5,938 | 5,790,489 | - | 0 | Common Stock | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2024 | 4,911 | 5,784,551 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 2,774 | 5,779,640 | - | 0 | Common Stock | |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 147.48 per share. | 15 Mar 2024 | 1,678 | 24,226 (0%) | 0% | 147.5 | 247,471 | Common Stock |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 147.48 per share. | 15 Mar 2024 | 750 | 24,976 (0%) | 0% | 147.5 | 110,610 | Common Stock |
| Sana Biotechnology Inc | Edgar Hans Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 4,901 | 5,776,866 | - | 0 | Common Stock | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 4,152 | 5,765,040 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 7,716 | 5,760,888 | - | 0 | Common Stock | |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 16 Mar 2023 | 1,658 | 21,638 (0%) | 0% | 136.8 | 226,848 | Common Stock |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 16 Mar 2023 | 741 | 22,379 (0%) | 0% | 136.8 | 101,384 | Common Stock |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 6,702 | 5,753,172 | - | 0 | Common Stock | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 4,012 | 5,746,470 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Hans Edgar Bishop | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 145,380 | 24,230 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Hans Edgar Bishop | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 08 Sep 2022 | 145,380 | 4,685,614 | - | 0.1 | 14,538 | Common Stock |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 3,328 | 5,742,458 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 2,880 | 5,739,130 | - | 0 | Common Stock | |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 17 Mar 2022 | 1,785 | 19,055 (0%) | 0% | 136.8 | 244,224 | Common Stock |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 17 Mar 2022 | 797 | 19,852 (0%) | 0% | 136.8 | 109,046 | Common Stock |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 121.59 per share. | 18 Mar 2021 | 1,850 | 16,353 (0%) | 0% | 121.6 | 224,947 | Common Stock |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 121.59 per share. | 18 Mar 2021 | 822 | 17,175 (0%) | 0% | 121.6 | 99,949 | Common Stock |
| Sana Biotechnology Inc | Hans E. Bishop | Director | 08 Feb 2021 | 2,031,250 | 5,736,250 | - | - | Common Stock | ||
| Sana Biotechnology Inc | Hans E. Bishop | Director | 08 Feb 2021 | 1,075,000 | 0 | - | - | Series A-1 Convertible Preferred Stock | ||
| Sana Biotechnology Inc | Hans E. Bishop | Director | 08 Feb 2021 | 800,000 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Sana Biotechnology Inc | Hans E. Bishop | Director | 08 Feb 2021 | 156,250 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Sana Biotechnology Inc | Hans E. Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 23,591 | 23,591 | - | - | Stock Option (Right to Buy) | |
| Agilent Technologies Inc. | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 93.91 per share. | 03 Aug 2020 | 177 | 14,455 (0%) | 0% | 93.9 | 16,622 | Common Stock |